LOW DENSITY LIPROPROTEIN CHOLESTEROL GOAL LEVELS IN CARDIOVASCULAR SECONDARY PREVENTION

Journal Title: WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE - Year 2017, Vol 6, Issue 6

Abstract

The Scandinavian Simvastatin Survival Study showed that the reduction of low density lipoprotein (LDL) cholesterol levels diminished 30% all causes mortality in coronary heart disease (CHD) patients. Later trials with statins indicated a positive relationship between CHD secondary prevention and continuously lower LDL-C levels. The Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High blood Cholesterol in Adults (Adult Treatment Panel III [ATP III]), recommended drug treatment of CHD or CHD risk equivalents patients, with LDL-C above 130 mg/dl and optional treatment between 100 and 129 mg/dl, with a goal value  100 mg/dl. In 2004, the same Program recommended an LDL-C goal of  70 mg/dl when cardiovascular risk is very high. This review examines main published clinical trials (2001-2016) of statins efficacy on CV secondary prevention, specially with LDL-C levels lower than 100 mg/dl and discusses its implementation at the current medical practice.

Authors and Affiliations

Gustavo H. Marin

Keywords

Related Articles

CONCEPTUAL STUDY OF OBESITY AND ITS MANAGEMENT BY AYURVEDA

Obesity is a multi-factorial metabolic disorder occupying major share in today’s life style disosrder. According to WHO India is the third most obese country of the world, the prevalence of obesity is higher in urban pop...

REASONS TO EXPLORE PHARMACIST’S ATTITUDE IN DISPENSING ANTIMICROBIAL AGENTS WITHOUT PRESCRIPTION DURING RAMADAN IN KARACHI

Introduction: Antimicrobials have saved millions of lives from life threatening infections, but these agents nowadays lose their effectiveness because of resistance due to their irrational or non-indicated use or use of...

STABILITY AND DISSOLUTION BEHAVIOUR OF CYCLODEXTRIN MOLECULAR INCLUSION COMPLEXES OF ARTEMETHER

This study aimed to assess the effect of inclusion complexation of artemether by 2-Hydroxypropyl-β-cyclodextrin on the dissolution and stabilization of the drug against degradation due to exposure to heat. Inclusion comp...

A REVIEW ON NANOCOCHLEATES NOVEL APPROACH FOR DRUG DELIVERY

Nanocochleate is a novel drug delivery system which have ability to enacapsulate the water soluble cationic drugs as well as hydrophobic and hydrophilic drugs. This nanotechnology is use encapsulate drug which have catio...

EXPLORING ANTI-HYPERGLYCEMIC POTENTIAL OF ALKALOID COMPOUNDS FROM CATHARANTHUS ROSEUS G. DON (L) AGAINST VARIOUS TYPE II DIABETES TARGETS BY IN SILICO VIRTUAL SCREENING

Background: Catharanthus roseus (L.) G. Don (C. roseus) is a prominent anticancer herb having high alkaloid content. Besides known anticancer effect, this plant has been also traditionally used as an effective anti-diabe...

Download PDF file
  • EP ID EP618220
  • DOI -
  • Views 151
  • Downloads 0

How To Cite

Gustavo H. Marin (2017). LOW DENSITY LIPROPROTEIN CHOLESTEROL GOAL LEVELS IN CARDIOVASCULAR SECONDARY PREVENTION. WORLD JOURNAL PHARMACY AND PHARMACEUTICAL SCIENCE, 6(6), 88-110. https://europub.co.uk./articles/-A-618220